Type | Private | |
Founded | 2006 | |
HQ | Austin, TX, US | Map |
Website | apolloendo.com | |
Employee Ratings | More |
Founding Date | 2006 |
Apollo Endosurgery total Funding | $186.8 m |
Apollo Endosurgery latest funding size | $22 m |
Time since last funding | 5 years ago |
Apollo Endosurgery investors | UT Horizon Fund, HIG Capital |
USD | |
---|---|
Revenue (Q3, 2020) | 12.8m |
Gross profit (Q3, 2020) | 7.0m |
Gross profit margin (Q3, 2020), % | 54.5% |
Net income (Q3, 2020) | (2.6m) |
EBIT (Q3, 2020) | (1.6m) |
Cash (30-Sept-2020) | 37.4m |
USD | Q2, 2011 | Q3, 2011 | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.5m | 1.8m | 2.8m | 1.3m | 1.4m | 1.1m | 2.0m | 2.6m | 1.7m | 1.3m | 1.1m | 783.9k | 747.6k | 61.3k | 9.6k | 9.2k | 23.8k | 14.6m | 17.1m | 16.5m | 15.7m | 7.3m | 6.7m | 13.2m | 14.3m | 11.3m | 10.7m | 5.6m | 12.8m |
Cost of goods sold | 5.1m | 6.6m | 6.0m | 6.6m | 6.0m | 7.1m | 5.8m | 5.1m | 3.2m | 5.8m | |||||||||||||||||||
Gross profit | 9.5m | 10.5m | 10.5m | 9.2m | 7.2m | 7.2m | 5.4m | 5.6m | 2.4m | 7.0m | |||||||||||||||||||
Gross profit Margin, % | 65% | 61% | 64% | 58% | 55% | 50% | 48% | 53% | 43% | 54% |
USD | Q2, 2011 | Q3, 2011 | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 18.7m | 15.9m | 17.8m | 18.2m | 16.0m | 20.5m | 17.5m | 14.9m | 16.1m | 14.3m | 20.5m | 12.7m | 11.9m | 11.6m | 7.0m | 4.7m | 3.3m | 8.3m | 5.3m | 34.6m | 22.3m | 30.0m | 22.9m | 35.0m | 23.2m | 19.1m | 37.4m | ||
Accounts Receivable | 869.2k | 1.9m | 3.4m | 642.5k | 372.5k | 228.1k | 382.3k | 622.2k | 2.7m | 1.3m | 2.1m | 1.4m | 731.9k | 56.0k | 9.6k | 9.2k | 24.9k | 10.0m | 12.8m | 12.3m | 11.9m | 10.6m | 11.2m | 8.9m | 7.5m | 5.7m | 8.2m | ||
Prepaid Expenses | 95.8k | 439.6k | 188.7k | 129.3k | 286.1k | 217.1k | 194.5k | 261.0k | 445.6k | 418.0k | 1.7m | 431.0k | 297.1k | 193.5k | 269.5k | 614.2k | 698.8k | 2.1m | 1.9m | 1.1m | 1.3m | 3.3m | 3.1m | 3.4m | 3.1m | 3.0m | 2.7m | ||
Inventories | 11.7m | 11.4m | 12.8m | 15.4m | 10.4m | 10.6m | 10.8m | 10.2m | 11.0m | 10.0m |
USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|---|---|---|---|---|---|
Net Income | (3.1m) | (2.8m) | (6.6m) | (16.6m) | (10.0m) | (41.2m) | (27.3m) | (45.8m) | (27.4m) |
Depreciation and Amortization | 142.0k | 187.5k | 196.2k | 216.1k | 467.0k | ||||
Inventories | (3.1m) | (2.8m) | 3.0m | 872.0k | |||||
Accounts Payable | 1.2m | (839.6k) | (179.4k) | 1.1m | (3.0m) | 523.0k | 4.7m | (1.3m) | (2.1m) |
USD | Q2, 2011 | Q3, 2011 | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | (275.8k) | 854.5k | 645.9k | (720.0) | (1.1m) | (1.2m) | (2.6m) | (5.2m) | (3.3m) | (7.0m) | (10.2m) | (2.8m) | (5.4m) | (7.7m) | (1.9m) | (4.6m) | (8.3m) | (8.2m) | (15.1m) | (20.0m) | (8.1m) | (17.7m) | (27.4m) | (2.8m) | (11.6m) | (20.2m) | (10.3m) | (16.5m) | (19.1m) |
Depreciation and Amortization | 37.2k | 65.8k | 21.5k | 47.2k | 75.0k | 42.0k | 129.0k | 161.5k | 35.9k | 98.9k | 167.0k | 70.6k | 142.4k | 262.3k | 45.4k | 672.3k | 135.1k | ||||||||||||
Inventories | 514.0k | 653.0k | (729.0k) | (1.2m) | (1.0m) | 439.0k | (502.0k) | (659.0k) | (1.0m) | (1.5m) | (2.3m) | (1.3m) | |||||||||||||||||
Accounts Payable | (917.9k) | (884.6k) | (1.1m) | (1.3m) | (1.3m) | (2.0m) | (1.4m) | (271.8k) | 502.0k | 195.4k | 131.6k | (1.1m) | (1.5m) | (2.0m) | (164.7k) | (260.3k) | 309.0k | 916.0k | 4.8m | 3.3m | 272.0k | (3.7m) | (3.0m) | 1.6m | 1.6m | 97.0k | 15.0k | (4.6m) | (7.3m) |
USD | Q2, 2011 |
---|---|
Financial Leverage | 6.7 x |
Apollo Endosurgery has 1.26k Twitter Followers. The number of followers has decreased 0.7% month over month and decreased 0.5% quarter over quarter
When was Apollo Endosurgery founded?
Apollo Endosurgery was founded in 2006.
Who are Apollo Endosurgery key executives?
Apollo Endosurgery's key executives are Todd Newton, David C. Pacitti and John Barr.
How many employees does Apollo Endosurgery have?
Apollo Endosurgery has 228 employees.
What is Apollo Endosurgery revenue?
Latest Apollo Endosurgery annual revenue is $50.7 m.
What is Apollo Endosurgery revenue per employee?
Latest Apollo Endosurgery revenue per employee is $222.4 k.
Who are Apollo Endosurgery competitors?
Competitors of Apollo Endosurgery include Optim, GC Aesthetics and Medequip.
Where is Apollo Endosurgery headquarters?
Apollo Endosurgery headquarters is located at 1120 S Capital of Texas Hwy #300, Austin.
Where are Apollo Endosurgery offices?
Apollo Endosurgery has offices in Austin, Crows Nest and Knaresborough.
How many offices does Apollo Endosurgery have?
Apollo Endosurgery has 5 offices.
Receive alerts for 300+ data fields across thousands of companies